Brown: Risk Weighti...
Health Care: Health Services
Derma Sciences Inc. (DSCI: NASDAQ)
$14.29 -0.06 | -0.42%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -12.07M | -4.34M | -2.45M | -1.14M |
| Operating Gains/Losses | 31.42K | 77.47K | 120.73K | -59.03K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -329.96K | -813.62K | -2.11M | -151.13K |
| (Increase) Decrease in Inventories | -3.27M | -292.00K | -1.12M | 1.00M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -399.92K | 237.10K | 368.55K | -367.40K |
| (Decrease) Increase In Other Current Liabilities | 1.44M | 243.07K | 764.33K | -800.64K |
| (Increase) Decrease In Other Working Capital | -4.54K | -641.00 | 310.94K | -440.00 |
| Other Non-Cash Items | 2.72M | 2.82M | 1.12M | 1.85M |
| Net Cash From Continuing Operations | -11.90M | 249.54K | -291.21K | 2.65M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -11.90M | 249.54K | -291.21K | 2.65M |
| Sale of Property, Plant & Equipment | 47.22K | 0.00 | 0.00 | 61.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -3.13M | -1.98M | -2.88M | -265.73K |
| Acquisitions | -14.36M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -6.47M | -5.47M | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -16.19M | -7.45M | -2.88M | -204.73K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 52.69M | 26.98M | 4.49M | 0.00 |
| Repayment of Long-Term Debt | -80.55K | -5.85K | -4.06M | -2.44M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -5.00K |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -3.08M | 2.80M | -323.46K |
| Net Cash From Financing Activities | 52.61M | 23.89M | 3.23M | -2.77M |
| Effect of Exchange Rate Changes | -4.97K | 15.75K | 103.88K | 169.97K |
| Net Change in Cash & Cash Equivalents | 24.51M | 16.71M | 160.69K | -147.51K |
Portfolios with DSCI
- Portfolio NameUser Type
- UserMedical devices M&A
- Contributor3 Small-Cap Stocks on Insid...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- UserTest Drive
- Contributor10 Cheap Biotech Stocks Tha...
- Contributor5 Health Care Stocks With U...
- ContributorBarron's Insider Purchases ...
- UserPINOCH
Latest DSCI Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- 3 Small-Cap Stocks on Insiders' Radar 11.18.11 | 01:11 pm
- Insiders Trading BBBY, ENTG, DSCI, CHKM 10.20.11 | 10:10 am
- 11 Biotech Stocks Loved or Hated by Hedge Funds 08.17.11 | 06:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Insiders Trading NS, TZOO, DSCI, CRR 05.28.11 | 03:05 pm
- Biotech Stock Mailbag: Fibrocell Science 05.27.11 | 06:05 am
- Derma Stock Soars (DSCI) 05.25.11 | 10:05 am
- Derma Sciences: Drug Extends Wound Healing 05.25.11 | 07:05 am
Press Releases for DSCI
- Derma Sciences Announces Timing For Fourth Quarter Conference Call And 2012 Form 10-K Filing - Business Wire 03.15.13 | 04:03 pm
- Derma Sciences To Present At The 25th Annual ROTH Conference - Business Wire 03.14.13 | 12:03 pm
- Derma Sciences Initiates Enrollment In DSC127 Phase 3 Trial For Healing Diabetic Foot Ulcers - Business Wire 02.06.13 | 08:02 am
- Derma Sciences Closes $36.4 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment - Business Wire 12.11.12 | 05:12 pm
- Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock - Business Wire 12.06.12 | 09:12 am
- Derma Sciences Announces Commencement Of Public Offering Of Common Stock - Business Wire 12.05.12 | 04:12 pm
- Derma Sciences To Present At Two Upcoming Conferences - Business Wire 11.30.12 | 02:11 pm
- Derma Sciences To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 08:11 am
- Derma Sciences To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 10:11 am
- Derma Sciences Reports Third Quarter 2012 Financial Results - Business Wire 11.12.12 | 07:11 am
Partner Headlines for DSCI
- Pre-Market Earnings Report for April 1, 2013 : CALM, DSCI - NASDAQ 03.28.13 | 08:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.04.12 | 09:12 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.29.12 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.20.12 | 09:11 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 09.12.11 | 09:09 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.31.11 | 09:03 am
